Date(Session) |
Motion details and subsequent actions taken |
Resolution |
Company‘s response to
Audit Committee‘s opinions |
2023/3/14
The 1st committee
5th |
1. Approved 2021 Business Report, Parent Company-only Financial Statements, and Consolidated Financial Statements.
2. Approved the assessment of the independence and suitability of CPAs.
3. Approved lending of funds between the Company and its subsidiaries. |
Approved by all Audit Committee members present. |
Approved by all
Directors present. |
2023/05/11
The 1st committee
6th |
1.Approved the Financial Consolidated Statement for the first quarter of 2023.
2.Motion to approve the fees for CPAs.
3. Approved the proposal for partial amendments to the “Procedures for Asset Acquisition and Disposal”. |
Approved by all Audit Committee members present. |
Approved by all
Directors present. |
2023/08/10
The 1st committee
7th |
1. Approved the Financial Consolidated Statement for the second quarter of 2023.
2. Approved endorsements/guarantees between the Company and its subsidiaries.
3. Approved lending of funds between the Company and its subsidiaries.
4. Motion to approve the participation in the private placement of common shares of HYE Technology Co., Ltd (stock code: 6877). |
Approved by all Audit Committee members present. |
Approved by all
Directors present. |
2023/10/11
The 1st committee
8th |
1. Motion to approve the Company’s disposal of the overseas subsidiaries which it held indirectly 100% of its shares.
2.Motion to approve the Company’s increase of the capital of the subsidiary in Mainland China.
3.Approved the motion for the Company's new investment in the perovskite industry. |
Approved by all Audit Committee members present. |
Approved by all
Directors present. |
2023/11/9
The 1st committee
9th |
1. Approved the Financial Consolidated Statement for the third quarter of 2023. |
Approved by all Audit Committee members present. |
Approved by all
Directors present. |
2023/12/26
The 1st committee
10th |
1. Approved the discussions about the revenue, profits, and capital expenditure of the Company and its subsidiaries in Mainland China for 2024.
2. Approved endorsements/guarantees between the Company and its subsidiaries.
3. Approved the 2023 Audit Plan.
4. Motion to approve the Company’s reinvestment in Mainland China. |
Approved by all Audit Committee |
Approved by all
Directors present. |